Anti-CLEC12A / CD371 Reference Antibody (tepoditamab)

SKU: orb1806237

Description

It is expressed from CHO. The heavy chain type is huIgG1, and the light chain type iskappa. It has a predicted MW of 144.5 kDa

Images & Validation

−

Item 1 of 2

Tested Applications	ELISA, FA, FACS, Kinetics
Reactivity	Human

Key Properties

−

Clonality	Monoclonal
Isotype	IgG
Target	CD3&CLEC12A
Molecular Weight	144.5 kDa
Purity	> 95%
Endotoxin	< 1 EU/mg
Conjugation	Unconjugated

Storage & Handling

−

Storage	24 months at -80°C
Form/Appearance	Transparent liquid
Buffer/Preservatives	Supplied as a 0.22 μm filtered solution in 50 mM Pro-Ac, pH 5.0
Concentration	2.39 mg/mL
Expiration Date	12 months from date of receipt.
Disclaimer	For research use only

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Anti-CLEC12A / CD371 Reference Antibody (tepoditamab)

The purity of the protein is 99.64% determined by SEC-HPLC

Tepoditamab on SDS-PAGE under non-reducing (NR) and reducing (R) conditions. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%

Quick Database Links

Gene Symbol

CD3&CLEC12A

Documents Download

Datasheet

Product Information

Download

Request a Document

Protocol Information

FACS

Fluorescence-Activated Cell Sorting (FC, Flow cytometry)

View Protocol

ELISA

Enzyme-linked Immunosorbent Assay (EIA)

View Protocol

Find More Protocols